The Healthcare Sector: A.I. and the G.O.P. debate

[00:02:05] Shift to topic on the global AI landscape.Mention of Rick's LinkedIn post on the AI strategic risk exposure between the U.S. and China.Importance of AI in global health.Highlight: Ian Bremmer's article in Foreign Affairs.[00:03:14] Dive into the AI zero-sum game between the U.S. and China.Both countries combined contribute over 70% of AI research.AI's potential impact on the healthcare sector, especially diagnostics.[00:04:31] The importance of collaboration in the AI sector.Potential countermeasures and strategic planning for international collaboration.Handling cross-border data flows and data-sharing protocols.Balancing shared goals, trust, and national interests.[00:06:13] Intellectual Property (IP) in the context of U.S.-China AI rivalry.Protection of IP to maintain competitive advantage.Adherence to international laws and agreements.Engaging experts when dealing internationally, especially in AI.[00:08:14] The conundrum of AI and IP ownership.Who owns the results produced by AI?The specificities around healthcare AI and establishing "guardrails" for IP.[00:09:00] U.S.-China rivalry's impact on global healthcare delivery.Effects on developing regions that might leverage technologies from both nations.China's Belt and Road initiative vs. U.S.'s focused assistance in developing countries.Emphasis on IP protection and global health leadership by the U.S.